RecallRadar

FDA Drug recall D-0323-2024

Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Geor…

On 2024-02-07 the FDA classified a Class I recall of Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Geor… by Azurity Pharmaceuticals, citing labeling: Label Mix-up.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0323-2024
ClassificationClass I
Statusterminated
Initiated2024-01-04
Published2024-02-07
Last updated2026-09-13 11:52 UTC
CompanyAzurity Pharmaceuticals
DistributionUS

Product

Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03

Reason

Labeling: Label Mix-up

Identifiers

ndc24338-850-03
ndc24338-851-03
ndc24338-852-03
ndc24338-853-03
ndc24338-854-03
ndc24338-855-03
ndc24338-856-03
code_infoLot # F230169A, Exp. 06/30/2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0323-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.